relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.

Latest action: Refer to Interim Study, MA, VV; 02/08/2024; SJ 3

Voted 2/8/2024

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

2/8/2024Refer to Interim Study, MA, VV; 02/08/2024; SJ 3
1/31/2024Committee Report: Referred to Interim Study, 02/08/2024, Vote 4-1; SC 6
1/4/2024Hearing: 01/10/2024, Room 101, LOB, 01:00 pm; SC 2
12/8/2023To Be Introduced 01/03/2024 and Referred to Health and Human Services; SJ 1